Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,152.00
Bid: 12,150.00
Ask: 12,154.00
Change: -18.00 (-0.15%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European shares at one-month high as Omicron fears fade

Thu, 23rd Dec 2021 09:34

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* STOXX 600 gains for third straight session

* Travel stocks rise on Omicron updates

* Banks track yields higher

* Holcim gains on $1.35 bln deal
(Updates to close)

By Anisha Sircar and Shashank Nayar

Dec 23 (Reuters) - European shares hit a one-month high on
Thursday, led by gains in banking stocks as signs the impact of
the Omicron variant may be less severe than feared led to
improved risk appetite that pushed eurozone and Treasury yields
higher.

The pan-European STOXX 600 gained 1%, marking the
third straight session of gains, boosted by banks and
travel stocks, tracking a global share rally that was
also helped by robust U.S. economic data.

Two vaccine makers said their shots protected against
Omicron as UK data suggested it may cause proportionally fewer
hospital cases than the Delta coronavirus variant, though public
health experts warned the battle against COVID-19 was far from
over.

Researchers from University of Edinburgh and Imperial
College London reported evidence that the Omicron variant was
less severe than the Delta coronavirus variant.

"The Omicron wave won't derail the economic recovery that's
well underway, it might delay it, but 2022 will have an
attractive, healthy economic environment," said Philip
Petursson, chief investment strategist at IG Wealth Management.

European government bond yields rose for the
fourth consecutive session and benchmark U.S. Treasury yields
rose to two-week highs as the trickle of risk
sentiment back into the market reduced the need for safe-haven
debt, helping push bank stocks higher.

The STOXX 600 is set to gain around 21% this year, mildly
underperforming a 26% gain in the S&P 500 and is a mere 1.5%
away from its record highs.

"This year, economies reopened from 2020 lockdowns and
benefited from all the fiscal stimulus. 2022 will be the path to
normalisation of equity returns, interest rates and economic
growth," Petursson said.

AstraZeneca added to the positive sentiment after
the drugmaker said a three-dose course of its COVID-19 vaccine
was effective against the Omicron variant, citing data from an
Oxford University lab study.

Swiss building materials company Holcim gained 1.9%
after saying it would buy Malarkey Roofing Products for $1.35
billion to expand into the growing U.S. residential roofing
market.

Flutter Entertainment rose 2.1% after announcing
it would buy Italian online gaming operator Sisal for 1.62
billion pounds ($2.16 billion), as the online betting group
looks to expand its footprint in Europe.

Continental AG added 2.5% after its CEO told a
magazine that the German automotive supplier could hit the upper
end of its profit margin outlook in 2021 as vehicle production
picked up in the fourth quarter.
(Reporting by Anisha Sircar and Shashank Nayar in Bengaluru;
Editing by Shounak Dasgupta and Barbara Lewis)

More News
Today 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.